Engineers Gate Manager LP Black Diamond Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $4.86 Billion
- Q3 2024
A detailed history of Engineers Gate Manager LP transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 18,411 shares of BDTX stock, worth $47,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,411
Previous 16,260
13.23%
Holding current value
$47,684
Previous $75,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BDTX
# of Institutions
120Shares Held
48.8MCall Options Held
1.84MPut Options Held
1.93M-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$27.8 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$22.1 Million0.62% of portfolio
-
Vestal Point Capital, LP New York, NY5.03MShares$13 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$11.5 Million1.48% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$8.33 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $94.1M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...